PT Murni Sadar Tbk (MTMH.JK)
IDR 900.0
(5.88%)
IDR 900.0
(5.88%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 490.08 Billion IDR | 48.67% |
| 2022 | 329.64 Billion IDR | 9.51% |
| 2021 | 301.02 Billion IDR | -52.85% |
| 2020 | 638.39 Billion IDR | -11.86% |
| 2019 | 724.3 Billion IDR | 21.73% |
| 2018 | 595 Billion IDR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 553.77 Billion IDR | 13.0% |
| 2024 Q3 | 553.75 Billion IDR | 3.93% |
| 2024 Q2 | 581.31 Billion IDR | 4.97% |
| 2023 Q3 | 476.67 Billion IDR | 9.42% |
| 2023 FY | 490.08 Billion IDR | 48.67% |
| 2023 Q4 | 490.08 Billion IDR | 2.81% |
| 2023 Q2 | 435.64 Billion IDR | 12.58% |
| 2023 Q1 | 386.96 Billion IDR | 17.39% |
| 2022 Q1 | 76.14 Billion IDR | -74.71% |
| 2022 Q4 | 329.64 Billion IDR | 29.61% |
| 2022 FY | 329.64 Billion IDR | 9.51% |
| 2022 Q3 | 254.34 Billion IDR | 97.43% |
| 2022 Q2 | 128.82 Billion IDR | 69.19% |
| 2021 FY | 301.02 Billion IDR | -52.85% |
| 2021 Q4 | 301.02 Billion IDR | -30.9% |
| 2021 Q3 | 435.64 Billion IDR | 0.0% |
| 2021 Q1 | 1.03 Billion IDR | 0.0% |
| 2020 FY | 638.39 Billion IDR | -11.86% |
| 2019 FY | 724.3 Billion IDR | 21.73% |
| 2018 FY | 595 Billion IDR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| PT Bundamedik Tbk | 497.89 Billion IDR | 1.569% |
| PT Metro Healthcare Indonesia Tbk | 427.86 Billion IDR | -14.54% |
| PT Medikaloka Hermina Tbk | 1405.68 Billion IDR | 65.136% |
| PT Mitra Keluarga Karyasehat Tbk | -839.7 Billion IDR | 158.364% |
| PT Famon Awal Bros Sedaya Tbk | 252.54 Billion IDR | -94.06% |
| PT Royal Prima Tbk | -26.49 Billion IDR | 1949.83% |
| PT Kedoya Adyaraya Tbk | -57.42 Billion IDR | 953.447% |
| PT Sarana Meditama Metropolitan Tbk | 834.93 Billion IDR | 41.303% |
| PT Siloam International Hospitals Tbk | -552.3 Billion IDR | 188.734% |
| PT Sejahteraraya Anugrahjaya Tbk | 1135.04 Billion IDR | 56.823% |